Ahmed; Mahmood

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ahmed; Mahmood.The latest application filed is for "anandamide compounds".

Company Profile

1.7.14

Ahmed; Mahmood - Singapore SG
Ahmed; Mahmood - Harlow GB
Ahmed; Mahmood - Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anandamide Compounds App 20220112225 - Silver; David Lawrence ; et al.	2022-04-14
Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists Grant 8,324,254 - Ahmed , et al. December 4, 2	2012-12-04
Quinoline derivatives and their use as 5-HT.sub.6 ligands Grant 8,236,947 - Ahmed , et al. August 7, 2	2012-08-07
Indole derivatives as S1P1 Receptor Grant 8,101,775 - Ahmed , et al. January 24, 2	2012-01-24
Quinoline Derivatives And Their Use As 5-ht6 Ligands App 20110237792 - AHMED; Mahmood ; et al.	2011-09-29
Quinoline derivatives and their use as 5-HT6 ligands Grant 7,977,337 - Ahmed , et al. July 12, 2	2011-07-12
Quinoline Derivatives And Their Use As 5-ht6 Ligands App 20100305107 - AHMED; Mahmood ; et al.	2010-12-02
Quinoline derivatives and their use as 5-HT.sub.6 ligands Grant 7,799,774 - Ahmed , et al. September 21, 2	2010-09-21
Oxadiazole Substituted Indazole Derivatives For Use As Sphingosine 1-phosphate (s1p) Agonists App 20100113528 - Ahmed; Mahmood ; et al.	2010-05-06
Indole Derivatives As S1p1 Receptor App 20100113796 - AHMED; Mahmood	2010-05-06
Oxadiazole Derivates As S1p1 Receptor Agonists App 20100048639 - Ahmed; Mahmood ; et al.	2010-02-25
Quinoline Derivatives And Their Use As 5-ht6 Ligands App 20090298841 - Ahmed; Mahmood ; et al.	2009-12-03
Quinoline derivatives and their use as 5-HT6 ligands Grant 7,601,837 - Ahmed , et al. October 13, 2	2009-10-13
Quinoline Derivatives and Their Use as 5-HT6 Ligands App 20090036682 - AHMED; Mahmood ; et al.	2009-02-05
Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 Receptor App 20090012056 - Ahmed; Mahmood ; et al.	2009-01-08
5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders App 20080318933 - Ahmed; Mahmood ; et al.	2008-12-25
Quinoline derivatives and their use as 5-ht6 ligands Grant 7,452,888 - Ahmed , et al. November 18, 2	2008-11-18
Novel Compounds App 20070232657 - Ahmed; Mahmood ; et al.	2007-10-04
3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders App 20070191345 - Ahmed; Mahmood ; et al.	2007-08-16
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders App 20050176759 - Ahmed, Mahmood ; et al.	2005-08-11
Sulphonyl compounds with 5-ht6 receptor affinity App 20050090496 - Ahmed, Mahmood ; et al.	2005-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.